Lupin LimitedNSE: LUPIN

Press Release Oct 04 2022

· Issued by Lupin Limited

Lupin Limited has informed the Exchange about press release dated 04-Oct-2022 titled Lupin Receives Approval from U.S. FDA for Darunavir Tablets.

View Attachment